Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

3 Stocks Using Buybacks to Drive Sustainable Price Growth

Buybacks can help investors gain leverage if they reduce the share count and are sustained over time. These stocks meet the criteria, expected to rise in Q4.

Why These 3 Tech Stocks Deserve Your Attention in Q4

Why These 3 Tech Stocks Deserve Your Attention in Q4

Tech stocks like Braze, MongoDB, and LightPath present opportunities in Q4 investors should be aware of. The upside is robust, and the downside limited.

Is BigBear.ai the Next Palantir?

Is BigBear.ai the Next Palantir?

With AI defense ties, $380M in backlogs, and big-name investors, early-stage stock BigBear.ai (BBAI) is gaining momentum—and could be the next Palantir (PLTR).

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

General Dynamics Hits New Highs: Why It Might Keep Climbing

General Dynamics' stock reaches a new all-time high, driven by major defense contracts, strong earnings, and future growth catalysts in its aerospace division

Nike’s Turnaround: If the Shoe Fits, Buy It!

Nike is well-positioned to regain business momentum and create shareholder value. Analysts liked the Q1 report and signaled a rebound in stock prices.

NVIDIA Breaks Out to New Highs: What Comes Next?

NVIDIA's stock price breakout is bullish for its direction and the S&P 500. Analysts and technical targets align; a 20% upside lies ahead.

Microsoft Stock Hits Stride in 2025—How Much More Can It Run?

Microsoft stock is up 23% in 2025, but analysts see more upside ahead as AI and cloud growth fuel its consistent long-term performance

inkl

Read news from The Economist, FT, and more,
with one subscription

How Berkshire's OxyChem Buy Cements Its Long-Term Strength

How Berkshire's OxyChem Buy Cements Its Long-Term Strength

Berkshire Hathaway's multi-billion-dollar acquisition of OxyChem signals a strategic deployment of cash into a stable, long-term industrial earnings engine.

Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry

Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry

Oklo's insiders sold in Q2 and Q3, but this poses no threat to investors; institutions and analysts offset it, while short-sellers are a bigger risk.

Rocket Lab's Electron: The Quiet Workhorse Powering Momentum

Rocket Lab's Electron: The Quiet Workhorse Powering Momentum

Despite Neutron grabbing the headlines, Electron remains the company’s backbone, with 70 launches to date and expanding multi-launch contracts.

Down 22% From Highs, ServiceNow Could Be Too Cheap to Ignore

Down 22% From Highs, ServiceNow Could Be Too Cheap to Ignore

The nearly $200 billion software giant ServiceNow has fallen 14% in 2025. However, with strong and improving fundamentals, recent price targets eye +30% upside.

Oil Set to Rebound? 3 Stocks That Win if Crude Climbs

Oil Set to Rebound? 3 Stocks That Win if Crude Climbs

Crude oil may rise on OPEC+ cuts and seasonal demand. Exxon, Chevron, and Schlumberger are well-positioned for investors seeking energy upside

The New Brain of Business: UiPath Is Creating an AI Revolution

The New Brain of Business: UiPath Is Creating an AI Revolution

UiPath's strategic partnerships are embedding it as the essential orchestration layer for the future of enterprise AI and automation.

Buy The Dip Opportunity: Paychex Signals Rebound After Sell-Off

Buy The Dip Opportunity: Paychex Signals Rebound After Sell-Off

Paychex's dividend is a worthwhile investment; it is expected to grow along with the company's business. Institutions are accumulating the stock in 2025.

Get all your
news in one place.

100’s of premium titles.
One news app.

3 Lesser-Known Healthcare Names With Major Upside in Store

These are three healthcare stocks offering a compelling combination of secure business, strong fundamentals, and growth opportunity.

Why Insurance Stocks May Struggle Despite Strong Highs

Insurance stocks are near record highs, but climate risks and looming rate cuts could pressure margins and challenge the sector’s defensive reputation

Datavault AI: The New AI Contender Backed by Big Funding

Datavault AI's recent nine-figure investment and a partnership with IBM signal a fundamental inflection point for this emerging AI growth company.

CoreWeave: Why the New King of AI Infrastructure Has Room to Run

A landmark agreement with Meta Platforms crowns CoreWeave as the premier provider of specialized cloud infrastructure for the most demanding AI workloads.

Get all your
news in one place.

100’s of premium titles.
One news app.

Top 3 Dividend Achievers for October: High Yields, Growth Ahead

High-yield Dividend Achievers, such as United Parcel Service, Verizon, and Pfizer, offer attractive entry points in October for income investors.

Etsy Partners With OpenAI—What It Means for Investors Now

Etsy is on track to complete a reversal, but investors should be patient; forces are in play that point to volatility ahead of the Q3 earnings release.

3 Solid Consumer Brands Offering Stability in Volatile Markets

These consumer-facing companies have seemed to struggle in recent months, but looking closely under the hood they may be more stable than investors imagine.

Lamb Weston: Is the King of Spuds a Buy or a Dud for 2026?

Lamb Weston reaffirmed its capital return outlook and reinvigorated its market. This stock has the potential to rise significantly over the next two years.

Palantir Stock Eyes New Highs, Boosted by Boeing Partnership

Palantir’s Boeing partnership strengthens its role in defense and commercial sectors, fueling stock momentum and challenging short sellers

Marvell Soars on +$6B in Buybacks—Can the Recovery Continue?

AI chip designer Marvell is gaining after its new buyback plan and updates on its Amazon business. Down over 50% from highs, shares could be ready to run.

Is Intuitive Surgical the Hidden Winner in Healthcare’s Weakness?

Intuitive Surgical (NASDAQ: ISRG) trades 29% off its highs despite strong growth, leasing model expansion, and analyst targets calling for 40% upside.

1 … 13 14 15 16

People

King Charles III

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Berkshire Hathaway

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play